The platform's lead drug candidate, ResectAssist™-FOLFIRINOX, focuses on LAPC, delivering high-dose FOLFIRINOX chemotherapy (5-fluorouracil, leucovorin, irinotecan, and oxaliplatin) directly into ...

OSE Immunotherapeutics Announces Positive Clinical Progress for Late-Stage Proprietary Cancer Vaccine Tedopi® ARTEMIA: Clinical trial protocol ...

Lisata Therapeutics, Inc. (Nasdaq: LSTA) ("Lisata”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, ...

Disorders of peripheral nerves are frequent complications of chemotherapy and certain other drug therapies. As more and more effective therapies for cancer are found and patients are living longer, ...

Expert Rev Anticancer Ther. 2012;12(10):1327-1336. From a clinical perspective, it is intriguing to see that the issue of 'lines of therapy' is being discussed in a disease as devastating as ...

The total cost of cancer treatment and a Medicare plan is between $4,361 and $10,872 per year, based on the type of plan you choose. Without insurance, the average cost of chemotherapy and cancer ...

A community hospital in West Somserset has begun offering chemotherapy for the first time. The NHS Somerset Foundation Trust said it is able to take advantage of unused clinical space at Williton ...